KD Ventures

KD-Ventures is the corporate venture capital and incubation arm of the KD Pharma Group, a global leader in lipid technology and Omega-3 pharmaceutical manufacturing. The company focuses on investing in and developing advanced drug delivery systems, lipid-based therapeutics, and synthetic chemistry platforms. KD-Ventures manages a portfolio of innovative projects and strategic investments, leveraging the parent company's GMP manufacturing and R&D expertise. Key areas of focus include cardiovascular health, metabolic diseases like obesity, and inflammatory conditions such as ulcerative colitis. Through its partnership model, KD-Ventures accelerates the transition of early-stage lipid technologies into clinical-stage pharmaceutical products.